SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: D.Right who wrote (1276)3/13/1998 8:51:00 AM
From: Rudy Saucillo  Respond to of 2173
 
Greetings, D.Right.

BioCentury's web site (http://www.biocentury.com) usually has a sample article from the current newsletter. The sample from this week's newsletter does mention AMLN but, unfortunately, is not the lead article I was referring to. Check out the "New this week" link on their site. It's a nice site with a number of useful links.

Rudy



To: D.Right who wrote (1276)3/19/1998 3:49:00 PM
From: D.Right  Read Replies (1) | Respond to of 2173
 
AMLN finished Europe and Canada patient enrollment for two six months trial IIIs.

biz.yahoo.com

When you are not hot, you are really cold. This otherwise quite positive news has no effect on the stock at all. At least we know how long we have to wait now.

Hong on everyone.

D.Right